StockNews.com assumed coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research note issued to investors on Saturday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Trading Down 5.9 % Shares of NASDAQ:TTNP opened at $0.26 on Friday. Titan Pharmaceuticals has a one year low […]